Skye Bioscience, Inc.
Q4 2023 13F Holders
Symbol
SKYE
CUSIP
83086J200
Type
Equity
Class
COM NEW
Num filings
1
Total reported value, excl. options
$4.35 k
Compare 2023 Q4 to
2026 Q2
2026 Q1
2025 Q4
2025 Q3
2025 Q2
2025 Q1
2024 Q4
2024 Q3
2024 Q2
2024 Q1
Manager
Report Date
Value ($000)
Shares
Option Type